Ficolins and infectious diseases
- 831 Downloads
Ficolins are serum complement lectins, with a structure similar to mannose-binding lectin (MBL) and lung surfactant protein (SP)-A and SP-D. Ficolins activate the lectin complement system and play important roles in host innate immunity. Ficolins are members of the collectin family of proteins, which act as pattern recognition receptors (PRRs). They are soluble oligomeric defense proteins with lectin-like activity, and are able to recognize pathogen-associated molecular patterns (PAMPs), which are carbohydrate molecules on the surface of pathogens, and of apoptotic, necrotic, and malignant cells. Upon binding to their specific PAMPs, ficolins may trigger activation of the immune system either (1) by initiating activation of complement via the lectin pathway, (2) by a primitive type of opsonophagocytosis, or (3) by stimulating secretion of the inflammatory cytokines interferon (IFN)-Γ, interleukin (IL)-17, IL-6, and tumor necrosis factor (TNF)-α, and production of nitric oxide (NO) by macrophages, thus limiting the infection and concurrently orchestrating the subsequent adaptive immune response. Recently, a number of reports have shown that dysfunction or abnormal expression of ficolins may play crucial roles in viral and bacterial diseases and in inflammation. This review summarizes the reports on the roles of ficolins in the infectious diseases, and provides insight into ficolins as novel innate immune therapeutic options to treat these diseases.
KeywordsL-ficolin H-ficolin M-ficolin virus bacteria
Unable to display preview. Download preview PDF.
- Chang W C, Hartshorn K L, White M R, Moyo P, Michelow I C, Koziel H, Kinane B T, Schmidt E V, Fujita T, and Takahashi K. 2011. Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin. Biochem Pharmacol, 81: 388–395.PubMedCentralPubMedCrossRefGoogle Scholar
- Egli A, Schafer J, Osthoff M, Thiel S, Mikkelsen C, Rauch A, Hirsch H H, Bucher H C, Young J, Jensenius J C, Battegay M, and Trendelenburg M. 2013. Low levels of mannan-binding lectin or ficolins are not associated with an increased risk of cytomegalovirus disease in HIV-infected patients. PLoS One, 8: e51983.PubMedCentralPubMedCrossRefGoogle Scholar
- Gokudan S, Muta T, Tsuda R, Koori K, Kawahara T, Seki N, Mizunoe Y, Wai S N, Iwanaga S, and Kawabata S. 1999. Horseshoe crab acetyl group-recognizing lectins involved in innate immunity are structurally related to fibrinogen. Proc Natl Acad Sci U S A, 96: 10086–10091.PubMedCentralPubMedCrossRefGoogle Scholar
- Lynch N J, Roscher S, Hartung T, Morath S, Matsushita M, Maennel D N, Kuraya M, Fujita T, and Schwaeble W J. 2004. L-ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J Immunol, 172: 1198–1202.PubMedGoogle Scholar
- Michelow I C, Dong M, Mungall B A, Yantosca L M, Lear C, Ji X, Karpel M, Rootes C L, Brudner M, Houen G, Eisen D P, Kinane T B, Takahashi K, Stahl G L, Olinger G G, Spear G T, Ezekowitz R A, and Schmidt E V. 2010. A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus. J Biol Chem, 285: 24729–24739.PubMedCrossRefGoogle Scholar
- Rorvig S, Honore C, Larsson L I, Ohlsson S, Pedersen C C, Jacobsen L C, Cowland J B, Garred P, and Borregaard N. 2009. Ficolin-1 is present in a highly mobilizable subset of human neutrophil granules and associates with the cell surface after stimulation with fMLP. J Leukoc Biol, 86: 1439–1449.PubMedCrossRefGoogle Scholar
- Tsujimura M, Ishida C, Sagara Y, Miyazaki T, Murakami K, Shiraki H, Okochi K, and Maeda Y. 2001. Detection of serum thermolabile beta-2 macroglycoprotein (Hakata antigen) by enzyme-linked immunosorbent assay using polysaccharide produced by Aerococcus viridans. Clin Diagn Lab Immunol, 8: 454–459.PubMedCentralPubMedGoogle Scholar
- Verma A, White M, Vathipadiekal V, Tripathi S, Mbianda J, Ieong M, Qi L, Taubenberger J K, Takahashi K, Jensenius J C, Thiel S, and Hartshorn K L. 2012. Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses. J Immunol, 189: 2478–2487.PubMedCentralPubMedCrossRefGoogle Scholar